Madalina

Prohibition Partners LIVE is happy to announce Grass & Co., a leading British CBD and botanicals brand, as a main sponsor for the first event of the year, taking place on 18-20 May.

Born out of extensive and detailed data and consumer research into the established North American CBD markets, Grass & Co. was launched in the UK to champion the benefits of CBD and make it relevant and accessible to all within the mainstream market.

Returning as a Prohibition Partners LIVE sponsor for the second year running, CanX CBD Processing Corp is a global leader in cannabis extraction, biomass cultivation, and manufacturing wholesale CBD derivatives. From cultivating and harvesting biomass to state-of-the-art ethanol extraction, CanX CBD covers the entire CBD supply and distribution chain—farming, processing, shipping, customer service, and logistics.

Prohibition Partners LIVE is pleased to announce WeedMD, a leading Candian federally-licensed producer of cannabis products, as a main sponsor for the first event of the year, taking place on 18-20 May.

WeedMD Inc. is the publicly traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., licence holders, producing and distributing premium cannabis products for both the medical and adult-use markets.

Prohibition Partners LIVE is proud to announce Global Cannabis Applications Corp. (GCAC), a leading developer of innovative data technologies for the medical cannabis industry, as a main sponsor for the first event of the year, taking place on 18-20 May.

GCAC’s innovative Ethereum-powered platform, Citizen Green Efixii, aims to solve one of the principal pain points for medical cultivators and consumers alike – the compliance, authentication, tracking, and certification of products to ensure quality, consistency, and most importantly, efficacy.

Starting from today, Prohibition Partners LIVE will be launching four days of disruptive debate from the most inspirational thinkers, leaders and pioneers within the global cannabis industry. We will kickstart the conference with our inaugural Science & Research Day; welcoming world-leading speakers, researchers and scientists across our three virtual stages for the day: Cannabis Europa, Cannabis Americana and PSYCH.

Prohibition Partners continues to align itself with industry leaders that are unlocking the potential of cannabis through science and innovation. The organization therefore is proud to announce Boveda, the original terpene shield™, as a sponsor of 2020 Prohibition Partners Live . This global cannabis conference is scheduled to be held virtually from November 17 through 22, 2020.

VerdeMed is a Canadian-based company bringing affordable cannabis-based treatments to patients across Latin America. The company has a multi-market approach, aiming to bridge the gap between the European and North American pharmaceutical cannabis landscape and Latin America’s unmet clinical needs. It is an honor for Prohibition Partners Live to work with Verdemed who are a frontrunner in the Latin American medicinal cannabis landscape.

MediPharm Labs – the global leader in pharma-quality cannabinoid-based products delivers on its promise in the production of pharmaceutical grade cannabis oils, concentrates, and advanced derivative products. Founded in Canada in 2015, MediPharm’s production utilizes a Good Manufacturing Practices certified facility with ISO standard-built clean rooms.

CanX CBD Processing Corp is a global leader in cannabis extraction, biomass cultivation, and manufacturing wholesale CBD derivatives.They are operating a state-of-the-art GMP, HACCP, ISO 22000, ISO19001:2011 and Kosher certified food grade ethanol extraction facility in Romanian where it manufactures derivatives from CBD Oils to Isolates.

Hill Dickinson’s expertise in corporate law, regulatory, commodities, international trade and healthcare law uniquely positions the firm to advise established and start-up medical cannabis and CBD/wellness companies in the UK and Europe on areas including: